Posted on: Feb 17, 2021 04:00PM
Combination Hormonal Therapy Seems More Effective for Men With Hormone-Receptor-Positive Breast Cancer
February 16, 2021
The combination of either tamoxifen or an aromatase inhibitor plus a gonadotropin-releasing hormone analogue reduced levels of estradiol, a form of estrogen, more than tamoxifen alone in men diagnosed with hormone-receptor-positive breast cancer. Read more...